367 related articles for article (PubMed ID: 33125401)
1. Baseline gut microbiome composition predicts metformin therapy short-term efficacy in newly diagnosed type 2 diabetes patients.
Elbere I; Silamikelis I; Dindune II; Kalnina I; Ustinova M; Zaharenko L; Silamikele L; Rovite V; Gudra D; Konrade I; Sokolovska J; Pirags V; Klovins J
PLoS One; 2020; 15(10):e0241338. PubMed ID: 33125401
[TBL] [Abstract][Full Text] [Related]
2. Trans-ethnic gut microbiota signatures of type 2 diabetes in Denmark and India.
Alvarez-Silva C; Kashani A; Hansen TH; Pinna NK; Anjana RM; Dutta A; Saxena S; Støy J; Kampmann U; Nielsen T; Jørgensen T; Gnanaprakash V; Gnanavadivel R; Sukumaran A; Rani CSS; Færch K; Radha V; Balasubramanyam M; Nair GB; Das B; Vestergaard H; Hansen T; Mande SS; Mohan V; Arumugam M; Pedersen O
Genome Med; 2021 Mar; 13(1):37. PubMed ID: 33658058
[TBL] [Abstract][Full Text] [Related]
3. Gut microbiome encoded purine and amino acid pathways present prospective biomarkers for predicting metformin therapy efficacy in newly diagnosed T2D patients.
Elbere I; Orlovskis Z; Ansone L; Silamikelis I; Jagare L; Birzniece L; Megnis K; Leskovskis K; Vaska A; Turks M; Klavins K; Pirags V; Briviba M; Klovins J
Gut Microbes; 2024; 16(1):2361491. PubMed ID: 38868903
[TBL] [Abstract][Full Text] [Related]
4. Metformin-induced changes of the gut microbiota in healthy young men: results of a non-blinded, one-armed intervention study.
Bryrup T; Thomsen CW; Kern T; Allin KH; Brandslund I; Jørgensen NR; Vestergaard H; Hansen T; Hansen TH; Pedersen O; Nielsen T
Diabetologia; 2019 Jun; 62(6):1024-1035. PubMed ID: 30904939
[TBL] [Abstract][Full Text] [Related]
5. Gut Microbiome Profiles Are Associated With Type 2 Diabetes in Urban Africans.
Doumatey AP; Adeyemo A; Zhou J; Lei L; Adebamowo SN; Adebamowo C; Rotimi CN
Front Cell Infect Microbiol; 2020; 10():63. PubMed ID: 32158702
[TBL] [Abstract][Full Text] [Related]
6. Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota.
Forslund K; Hildebrand F; Nielsen T; Falony G; Le Chatelier E; Sunagawa S; Prifti E; Vieira-Silva S; Gudmundsdottir V; Pedersen HK; Arumugam M; Kristiansen K; Voigt AY; Vestergaard H; Hercog R; Costea PI; Kultima JR; Li J; Jørgensen T; Levenez F; Dore J; ; Nielsen HB; Brunak S; Raes J; Hansen T; Wang J; Ehrlich SD; Bork P; Pedersen O
Nature; 2015 Dec; 528(7581):262-266. PubMed ID: 26633628
[TBL] [Abstract][Full Text] [Related]
7. Metformin Is Associated With Higher Relative Abundance of Mucin-Degrading Akkermansia muciniphila and Several Short-Chain Fatty Acid-Producing Microbiota in the Gut.
de la Cuesta-Zuluaga J; Mueller NT; Corrales-Agudelo V; Velásquez-Mejía EP; Carmona JA; Abad JM; Escobar JS
Diabetes Care; 2017 Jan; 40(1):54-62. PubMed ID: 27999002
[TBL] [Abstract][Full Text] [Related]
8. Metformin and gut microbiota: their interactions and their impact on diabetes.
Vallianou NG; Stratigou T; Tsagarakis S
Hormones (Athens); 2019 Jun; 18(2):141-144. PubMed ID: 30719628
[TBL] [Abstract][Full Text] [Related]
9. Metformin Reduces Blood Glucose in Treatment-Naive Type 2 Diabetes by Altering the Gut Microbiome.
He D; Han H; Fu X; Liu A; Zhan Y; Qiu H; Ma L; Zhang X; Wang X
Can J Diabetes; 2022 Mar; 46(2):150-156. PubMed ID: 35148952
[TBL] [Abstract][Full Text] [Related]
10. Combined effects of
Shin NR; Gu N; Choi HS; Kim H
Am J Physiol Endocrinol Metab; 2020 Jan; 318(1):E52-E61. PubMed ID: 31770016
[TBL] [Abstract][Full Text] [Related]
11. Gut microbiota of patients with type 2 diabetes and gastrointestinal intolerance to metformin differs in composition and functionality from tolerant patients.
Díaz-Perdigones CM; Muñoz-Garach A; Álvarez-Bermúdez MD; Moreno-Indias I; Tinahones FJ
Biomed Pharmacother; 2022 Jan; 145():112448. PubMed ID: 34844104
[TBL] [Abstract][Full Text] [Related]
12. Gut microbiota in patients with COVID-19 and type 2 diabetes: A culture-based method.
Petakh P; Kobyliak N; Kamyshnyi A
Front Cell Infect Microbiol; 2023; 13():1142578. PubMed ID: 36844398
[TBL] [Abstract][Full Text] [Related]
13. Association of metformin administration with gut microbiome dysbiosis in healthy volunteers.
Elbere I; Kalnina I; Silamikelis I; Konrade I; Zaharenko L; Sekace K; Radovica-Spalvina I; Fridmanis D; Gudra D; Pirags V; Klovins J
PLoS One; 2018; 13(9):e0204317. PubMed ID: 30261008
[TBL] [Abstract][Full Text] [Related]
14. Snapshot into the Type-2-Diabetes-Associated Microbiome of a Romanian Cohort.
Gradisteanu Pircalabioru G; Chifiriuc MC; Picu A; Petcu LM; Trandafir M; Savu O
Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499348
[TBL] [Abstract][Full Text] [Related]
15. Alteration of salivary microbiome in periodontitis with or without type-2 diabetes mellitus and metformin treatment.
Sun X; Li M; Xia L; Fang Z; Yu S; Gao J; Feng Q; Yang P
Sci Rep; 2020 Sep; 10(1):15363. PubMed ID: 32958790
[TBL] [Abstract][Full Text] [Related]
16. Metformin Strongly Affects Gut Microbiome Composition in High-Fat Diet-Induced Type 2 Diabetes Mouse Model of Both Sexes.
Silamiķele L; Silamiķelis I; Ustinova M; Kalniņa Z; Elbere I; Petrovska R; Kalniņa I; Kloviņš J
Front Endocrinol (Lausanne); 2021; 12():626359. PubMed ID: 33815284
[TBL] [Abstract][Full Text] [Related]
17. Gut microbiota compositions and metabolic functions in type 2 diabetes differ with glycemic durability to metformin monotherapy.
Hung WW; Peng P; Tsai YC; Jhou PS; Chang CC; Hsieh CC; Su YC; Dai CY; Hung WC
Diabetes Res Clin Pract; 2021 Apr; 174():108731. PubMed ID: 33676995
[TBL] [Abstract][Full Text] [Related]
18. Considering gut microbiota in treatment of type 2 diabetes mellitus.
Adeshirlarijaney A; Gewirtz AT
Gut Microbes; 2020 May; 11(3):253-264. PubMed ID: 32005089
[TBL] [Abstract][Full Text] [Related]
19. Gut microbiota varies by opioid use, circulating leptin and oxytocin in African American men with diabetes and high burden of chronic disease.
Barengolts E; Green SJ; Eisenberg Y; Akbar A; Reddivari B; Layden BT; Dugas L; Chlipala G
PLoS One; 2018; 13(3):e0194171. PubMed ID: 29596446
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive relationships between gut microbiome and faecal metabolome in individuals with type 2 diabetes and its complications.
Zhao L; Lou H; Peng Y; Chen S; Zhang Y; Li X
Endocrine; 2019 Dec; 66(3):526-537. PubMed ID: 31591683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
